NCT05796258View on ClinicalTrials.gov

Three-pronged Centralized Molecular Analysis to Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

July 26, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 4, 2024

Conditions

Thyroid Cancer

Interventions

DIAGNOSTIC_TEST

NTRK fusion assessment

To evaluate NTRK fusion presence by MCG, Immunohistochemistry or NGS

Trial Locations (1)

00144

Regina Elena National Cancer Institute, Roma

All Listed Sponsors

collaborator

University of Roma La Sapienza

OTHER

collaborator

Bambino Gesù Hospital and Research Institute

OTHER

lead

Regina Elena Cancer Institute

OTHER

NCT05796258 - Three-pronged Centralized Molecular Analysis to Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer | Biotech Hunter | Biotech Hunter